Featured
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
- Estimated to save individual Accredo patients around $4,000 per year
- Biosimilar price will be more than 80% lower than Stelara list price
- Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
